Shortening the time to confirm or to rebut Adverse events of interest related to innovative Therapies for immune-mediated inflammATory dIseases: cross-talking between different data sOURces. SATURATIOn study.

27/06/2024
27/06/2024
EU PAS number:
EUPAS1000000207
Study
Planned
Documents
Study protocol
Initial protocol
English (475.75 KB - PDF) View document
Study results
Study report
Other information